These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20435447)

  • 1. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.
    Schennach-Wolff R; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Jäger M; Möller HJ; Riedel M
    Eur Psychiatry; 2011; 26(5):284-92. PubMed ID: 20435447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
    Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective well-being, but not subjective mental functioning shows positive associations with neuropsychological performance in schizophrenia-spectrum disorders.
    Schroeder K; Huber CG; Jelinek L; Moritz S
    Compr Psychiatry; 2013 Oct; 54(7):824-30. PubMed ID: 23602393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders.
    Pinna F; Deriu L; Lepori T; Maccioni R; Milia P; Sarritzu E; Tusconi M; Carpiniello B;
    Psychiatry Res; 2013 Dec; 210(3):739-44. PubMed ID: 24007858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.
    de Haan L; Nimwegen Lv; Amelsvoort Tv; Dingemans P; Linszen D
    Pharmacopsychiatry; 2008 Jul; 41(4):125-8. PubMed ID: 18651339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years.
    Lambert M; Schimmelmann BG; Schacht A; Karow A; Wagner T; Wehmeier PM; Huber CG; Hundemer HP; Dittmann RW; Naber D
    Schizophr Res; 2009 Feb; 107(2-3):165-72. PubMed ID: 18842393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to assess subjective well-being among bipolar inpatients? An 18-week follow-up study.
    Altamura AC; Porcellana M; Marinaccio PM; Ciabatti M; Nocito EP; Magri L; Bressi C
    Gen Hosp Psychiatry; 2011; 33(2):185-90. PubMed ID: 21596212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
    Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Huff W; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Möller HJ; Riedel M
    Schizophr Res; 2009 Sep; 113(2-3):210-7. PubMed ID: 19560901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission as perceived by people with schizophrenia, family members and psychiatrists.
    Karow A; Naber D; Lambert M; Moritz S;
    Eur Psychiatry; 2012 Aug; 27(6):426-31. PubMed ID: 21571506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls.
    Vothknecht S; Meijer C; Zwinderman A; Kikkert M; Dekker J; van Beveren N; Schoevers R; de Haan L;
    Psychiatry Res; 2013 Mar; 206(1):62-7. PubMed ID: 23021423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
    Balestrieri M; Giaroli G; Mazzi M; Bellantuono C
    Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.
    Vothknecht S; Schoevers RA; de Haan L
    Aust N Z J Psychiatry; 2011 Mar; 45(3):182-92. PubMed ID: 21438745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride.
    Lambert M; Naber D; Eich FX; Schacht M; Linden M; Schimmelmann BG
    Acta Psychiatr Scand; 2007 Feb; 115(2):106-13. PubMed ID: 17244174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Spanish version of the Subjective Well-being under Neuroleptic Scale (SWN-K) in patients with schizophrenia].
    Sanjúan J; Haro JM; Mauriño J; Díez T; Ballesteros J
    Med Clin (Barc); 2012 Feb; 138(4):151-4. PubMed ID: 21571347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial.
    Chen L; Phillips G; Johnston J; Kinon BJ; Ascher-Svanum H; Kollack-Walker S; Succop P; Naber D
    BMC Psychiatry; 2011 Dec; 11():203. PubMed ID: 22204569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.